MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Patient satisfaction with flexible botulinum toxin injection intervals – Preliminary results of a telephone survey

C. Linder, S. Macher, E. Auff, T. Sycha (Vienna, Austria)

Meeting: 2016 International Congress

Abstract Number: 2065

Keywords: Blepharospasm, Botulinum toxin: Clinical applications: other, Spasticity: Treatment, Torticollis

Session Information

Date: Thursday, June 23, 2016

Session Title: Clinical trials and therapy in movement disorders

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To evaluate satisfaction with flexible injection intervals in patients receiving Botulinum toxin therapy at our outpatient clinic.

Background: Botulinum toxin therapy (BoNT) for muscular hyperactivity syndroms is widely given in fixed 3-month injection intervals. Since 2014, patients at our BoNT outpatient clinic were instructed to ask the next appointment when symptoms substantially worsen again resulting in flexible injection intervals. However, to provide short-term BoNT treatments according to the patients need they can no longer select a specific physician for BoNT application.

Methods: At the end of 2015 we carried out a retrospective telephone survey. We tried to reach 55 BoNT patients still under treatment at our outpatient clinic and 55 patients no longer receiving BoNT at our clinic and asked for patient satisfaction.

Results: 26 of 37 patients still being treated at our department were content with the new flexible appointment system. Nevertheless, 19 of these 26 patients would prefer being injected by one physician regularly. Eleven of 37 patients were not or rather not content with our new appointment system. They all would prefer being treated by the same physician regularly. 16 of 41 patients not treated at our department any longer continuated their BoNT treatment elsewhere, 7 of these 16 patients on their own request and 9 of 16 patients because they had to leave our outpatient clinic due to lack of capacity. 15 of 16 patients are content due to flexible injection intervals or due to being treated by the same physician.

Conclusions: Most patients were satisfied being injected with flexible injection intervals and the possibility of receiving injections immediately when deterioration of symptoms occurs. The main reason for patient satisfaction in BoNT patients who left our department was being treated by the same physician.

To cite this abstract in AMA style:

C. Linder, S. Macher, E. Auff, T. Sycha. Patient satisfaction with flexible botulinum toxin injection intervals – Preliminary results of a telephone survey [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/patient-satisfaction-with-flexible-botulinum-toxin-injection-intervals-preliminary-results-of-a-telephone-survey/. Accessed September 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/patient-satisfaction-with-flexible-botulinum-toxin-injection-intervals-preliminary-results-of-a-telephone-survey/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An atypical and interesting feature of Parkinson´s disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • #23812 (not found)
  • Approaching Health Care Shaped by Generational Expectations (The AGE Study): Generational Perspective Related to Time
  • Application of the “5-2-1” Screening Criteria in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel: Interim Analysis from the DUOGLOBE Study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley